Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Management of Calcium Channel Blocker Toxicity in the Pediatric Patient.

Bartlett JW, Walker PL.

J Pediatr Pharmacol Ther. 2019 Sep-Oct;24(5):378-389. doi: 10.5863/1551-6776-24.5.378. Review.

2.

Defining Efficacy Estimands in Clinical Trials: Examples Illustrating ICH E9(R1) Guidelines.

Ratitch B, Goel N, Mallinckrodt C, Bell J, Bartlett JW, Molenberghs G, Singh P, Lipkovich I, O'Kelly M.

Ther Innov Regul Sci. 2019 Apr 9:2168479019841316. doi: 10.1177/2168479019841316. [Epub ahead of print]

PMID:
30966778
3.

Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice.

Ratitch B, Bell J, Mallinckrodt C, Bartlett JW, Goel N, Molenberghs G, O'Kelly M, Singh P, Lipkovich I.

Ther Innov Regul Sci. 2019 Apr 4:2168479019838827. doi: 10.1177/2168479019838827. [Epub ahead of print]

PMID:
30947539
4.

Exaggeration of PFS by blinded, independent, central review (BICR).

Stone A, Gebski V, Davidson R, Bloomfield R, Bartlett JW, Sabin A.

Ann Oncol. 2019 Feb 1;30(2):332-338. doi: 10.1093/annonc/mdy514.

PMID:
30475951
5.

Clinical Safety Outcomes in Patients With Nonvalvular Atrial Fibrillation on Rivaroxaban and Diltiazem.

Bartlett JW, Renner E, Mouland E, Barnes GD, Kuo L, Ha NB.

Ann Pharmacother. 2019 Jan;53(1):21-27. doi: 10.1177/1060028018795140. Epub 2018 Aug 13.

PMID:
30099888
6.

Covariate adjustment and estimation of mean response in randomised trials.

Bartlett JW.

Pharm Stat. 2018 Sep;17(5):648-666. doi: 10.1002/pst.1880. Epub 2018 Jul 11.

PMID:
29998483
7.

Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease.

Barnes J, Bartlett JW, Wolk DA, van der Flier WM, Frost C.

J Alzheimers Dis. 2018;64(2):631-642. doi: 10.3233/JAD-170841.

8.

Multiple imputation of missing data in nested case-control and case-cohort studies.

Keogh RH, Seaman SR, Bartlett JW, Wood AM.

Biometrics. 2018 Dec;74(4):1438-1449. doi: 10.1111/biom.12910. Epub 2018 Jun 5.

9.

Missing binary outcomes under covariate-dependent missingness in cluster randomised trials.

Hossain A, DiazOrdaz K, Bartlett JW.

Stat Med. 2017 Aug 30;36(19):3092-3109. doi: 10.1002/sim.7334. Epub 2017 May 29.

10.

Primary Immunization of Human Papillomavirus Vaccine in the Pediatric Population: What Is the Verdict Now?

Jones AN, Bartlett JW, Bates RA, So TY.

Clin Pediatr (Phila). 2017 Jun;56(7):605-615. doi: 10.1177/0009922817691826. Epub 2017 Feb 20. Review.

PMID:
28503996
11.

Growth of HIV-exposed uninfected, compared with HIV-unexposed, Zambian children: a longitudinal analysis from infancy to school age.

Rosala-Hallas A, Bartlett JW, Filteau S.

BMC Pediatr. 2017 Mar 16;17(1):80. doi: 10.1186/s12887-017-0828-6.

12.

White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy.

Fiford CM, Manning EN, Bartlett JW, Cash DM, Malone IB, Ridgway GR, Lehmann M, Leung KK, Sudre CH, Ourselin S, Biessels GJ, Carmichael OT, Fox NC, Cardoso MJ, Barnes J; Alzheimer's Disease Neuroimaging Initiative.

Hippocampus. 2017 Mar;27(3):249-262. doi: 10.1002/hipo.22690. Epub 2017 Jan 9.

13.

Bayesian correction for covariate measurement error: A frequentist evaluation and comparison with regression calibration.

Bartlett JW, Keogh RH.

Stat Methods Med Res. 2018 Jun;27(6):1695-1708. doi: 10.1177/0962280216667764. Epub 2016 Sep 28.

14.

Multiple imputation of missing covariates for the Cox proportional hazards cure model.

Beesley LJ, Bartlett JW, Wolf GT, Taylor JM.

Stat Med. 2016 Nov 20;35(26):4701-4717. doi: 10.1002/sim.7048. Epub 2016 Jul 21.

15.

The Authors Reply.

Bartlett JW, Harel O, Carpenter JR.

Am J Epidemiol. 2016 Jul 15;184(2):161. doi: 10.1093/aje/kww067. Epub 2016 Jun 29. No abstract available.

PMID:
27358267
16.

Missing covariates in competing risks analysis.

Bartlett JW, Taylor JM.

Biostatistics. 2016 Oct;17(4):751-63. doi: 10.1093/biostatistics/kxw019. Epub 2016 May 13.

17.

Missing continuous outcomes under covariate dependent missingness in cluster randomised trials.

Hossain A, Diaz-Ordaz K, Bartlett JW.

Stat Methods Med Res. 2017 Jun;26(3):1543-1562. doi: 10.1177/0962280216648357. Epub 2016 May 13.

18.

Asymptotically Unbiased Estimation of Exposure Odds Ratios in Complete Records Logistic Regression.

Bartlett JW, Harel O, Carpenter JR.

Am J Epidemiol. 2015 Oct 15;182(8):730-6. doi: 10.1093/aje/kwv114. Epub 2015 Sep 30.

19.

Corrigendum: Improving upon the efficiency of complete case analysis when covariates are MNAR (10.1093/biostatistics/kxu023).

Bartlett JW, Carpenter JR, Tilling K, Vansteelandt S.

Biostatistics. 2015 Jan;16(1):205. doi: 10.1093/biostatistics/kxu051. No abstract available.

20.

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival.

Skillbäck T, Farahmand B, Bartlett JW, Rosén C, Mattsson N, Nägga K, Kilander L, Religa D, Wimo A, Winblad B, Rosengren L, Schott JM, Blennow K, Eriksdotter M, Zetterberg H.

Neurology. 2014 Nov 18;83(21):1945-53. doi: 10.1212/WNL.0000000000001015. Epub 2014 Oct 22.

PMID:
25339208
21.

Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.

Paterson RW, Bartlett JW, Blennow K, Fox NC; Alzheimer's Disease Neuroimaging Initiative, Shaw LM, Trojanowski JQ, Zetterberg H, Schott JM.

Transl Psychiatry. 2014 Jul 29;4:e419. doi: 10.1038/tp.2014.58.

22.

Improving upon the efficiency of complete case analysis when covariates are MNAR.

Bartlett JW, Carpenter JR, Tilling K, Vansteelandt S.

Biostatistics. 2014 Oct;15(4):719-30. doi: 10.1093/biostatistics/kxu023. Epub 2014 Jun 6. Erratum in: Biostatistics. 2015 Jan;16(1):205.

23.

APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.

Manning EN, Barnes J, Cash DM, Bartlett JW, Leung KK, Ourselin S, Fox NC; Alzheimer's Disease NeuroImaging Initiative.

PLoS One. 2014 May 30;9(5):e97608. doi: 10.1371/journal.pone.0097608. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e104482.

24.

Evaluation of two-fold fully conditional specification multiple imputation for longitudinal electronic health record data.

Welch CA, Petersen I, Bartlett JW, White IR, Marston L, Morris RW, Nazareth I, Walters K, Carpenter J.

Stat Med. 2014 Sep 20;33(21):3725-37. doi: 10.1002/sim.6184. Epub 2014 Apr 30.

25.

Comparison of random forest and parametric imputation models for imputing missing data using MICE: a CALIBER study.

Shah AD, Bartlett JW, Carpenter J, Nicholas O, Hemingway H.

Am J Epidemiol. 2014 Mar 15;179(6):764-74. doi: 10.1093/aje/kwt312. Epub 2014 Jan 12.

26.

Multiple imputation of covariates by fully conditional specification: Accommodating the substantive model.

Bartlett JW, Seaman SR, White IR, Carpenter JR; Alzheimer's Disease Neuroimaging Initiative*.

Stat Methods Med Res. 2015 Aug;24(4):462-87. doi: 10.1177/0962280214521348. Epub 2014 Feb 12.

27.

Automated template-based hippocampal segmentations from MRI: the effects of 1.5T or 3T field strength on accuracy.

Macdonald KE, Leung KK, Bartlett JW, Blair M, Malone IB, Barnes J, Ourselin S, Fox NC; Alzheimer’s Disease Neuroimaging Initiative.

Neuroinformatics. 2014 Jul;12(3):405-12. doi: 10.1007/s12021-013-9217-y.

28.

Multiple imputation for handling systematically missing confounders in meta-analysis of individual participant data.

Resche-Rigon M, White IR, Bartlett JW, Peters SA, Thompson SG; PROG-IMT Study Group.

Stat Med. 2013 Dec 10;32(28):4890-905. doi: 10.1002/sim.5894. Epub 2013 Jul 16.

PMID:
23857554
29.

Socioeconomic and early-life factors and risk of being overweight or obese in children of Swedish- and foreign-born parents.

Khanolkar AR, Sovio U, Bartlett JW, Wallby T, Koupil I.

Pediatr Res. 2013 Sep;74(3):356-63. doi: 10.1038/pr.2013.108. Epub 2013 Jun 25.

PMID:
23799533
30.

Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls.

Barnes J, Carmichael OT, Leung KK, Schwarz C, Ridgway GR, Bartlett JW, Malone IB, Schott JM, Rossor MN, Biessels GJ, DeCarli C, Fox NC; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2013 Aug;34(8):1996-2002. doi: 10.1016/j.neurobiolaging.2013.02.003. Epub 2013 Mar 21.

31.

Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations.

Scahill RI, Ridgway GR, Bartlett JW, Barnes J, Ryan NS, Mead S, Beck J, Clarkson MJ, Crutch SJ, Schott JM, Ourselin S, Warren JD, Hardy J, Rossor MN, Fox NC.

J Alzheimers Dis. 2013;35(1):199-212. doi: 10.3233/JAD-121255.

32.

Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.

Leung KK, Bartlett JW, Barnes J, Manning EN, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2013 Feb 12;80(7):648-54. doi: 10.1212/WNL.0b013e318281ccd3. Epub 2013 Jan 9.

33.

Targeted recruitment using cerebrospinal fluid biomarkers: implications for Alzheimer's disease therapeutic trials.

Barnes J, Bartlett JW, Fox NC, Schott JM.

J Alzheimers Dis. 2013;34(2):431-7. doi: 10.3233/JAD-121936.

PMID:
23229078
34.

Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges.

Bartlett JW, Frost C, Mattsson N, Skillbäck T, Blennow K, Zetterberg H, Schott JM.

Biomark Med. 2012 Aug;6(4):391-400. doi: 10.2217/bmm.12.49. Review.

35.

The value of hippocampal and temporal horn volumes and rates of change in predicting future conversion to AD.

Macdonald KE, Bartlett JW, Leung KK, Ourselin S, Barnes J; ADNI investigators.

Alzheimer Dis Assoc Disord. 2013 Apr-Jun;27(2):168-73. doi: 10.1097/WAD.0b013e318260a79a.

36.

Accent processing in dementia.

Hailstone JC, Ridgway GR, Bartlett JW, Goll JC, Crutch SJ, Warren JD.

Neuropsychologia. 2012 Jul;50(9):2233-44. doi: 10.1016/j.neuropsychologia.2012.05.027. Epub 2012 Jun 1.

37.

Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers.

Lehmann M, Koedam EL, Barnes J, Bartlett JW, Barkhof F, Wattjes MP, Schott JM, Scheltens P, Fox NC; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2013 Jan;34(1):73-82. doi: 10.1016/j.neurobiolaging.2012.03.010. Epub 2012 Apr 18.

PMID:
22516280
38.

Investigating missing data in Alzheimer disease studies.

Schott JM, Bartlett JW.

Neurology. 2012 May 1;78(18):1370-1. doi: 10.1212/WNL.0b013e318253d66b. Epub 2012 Apr 4. No abstract available.

PMID:
22491868
39.

Multiple imputation of missing covariates with non-linear effects and interactions: an evaluation of statistical methods.

Seaman SR, Bartlett JW, White IR.

BMC Med Res Methodol. 2012 Apr 10;12:46. doi: 10.1186/1471-2288-12-46.

40.

Voice processing in dementia: a neuropsychological and neuroanatomical analysis.

Hailstone JC, Ridgway GR, Bartlett JW, Goll JC, Buckley AH, Crutch SJ, Warren JD.

Brain. 2011 Sep;134(Pt 9):2535-47. doi: 10.1093/brain/awr205.

41.

Multiple imputation models should incorporate the outcome in the model of interest.

Bartlett JW, Frost C, Carpenter JR.

Brain. 2011 Nov;134(Pt 11):e189; author reply e190. doi: 10.1093/brain/awr061. Epub 2011 Jun 6. No abstract available.

PMID:
21646332
42.

Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease.

Lehmann M, Koedam EL, Barnes J, Bartlett JW, Ryan NS, Pijnenburg YA, Barkhof F, Wattjes MP, Scheltens P, Fox NC.

Neurobiol Aging. 2012 Mar;33(3):627.e1-627.e12. doi: 10.1016/j.neurobiolaging.2011.04.003. Epub 2011 May 18.

43.

The structural neuroanatomy of music emotion recognition: evidence from frontotemporal lobar degeneration.

Omar R, Henley SM, Bartlett JW, Hailstone JC, Gordon E, Sauter DA, Frost C, Scott SK, Warren JD.

Neuroimage. 2011 Jun 1;56(3):1814-21. doi: 10.1016/j.neuroimage.2011.03.002. Epub 2011 Mar 6.

44.

Brain MAPS: an automated, accurate and robust brain extraction technique using a template library.

Leung KK, Barnes J, Modat M, Ridgway GR, Bartlett JW, Fox NC, Ourselin S; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Apr 1;55(3):1091-108. doi: 10.1016/j.neuroimage.2010.12.067. Epub 2010 Dec 31.

45.

Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42.

Schott JM, Bartlett JW, Fox NC, Barnes J; Alzheimer's Disease Neuroimaging Initiative Investigators.

Ann Neurol. 2010 Dec;68(6):825-34. doi: 10.1002/ana.22315.

PMID:
21181717
46.

Gray matter atrophy rate as a marker of disease progression in AD.

Anderson VM, Schott JM, Bartlett JW, Leung KK, Miller DH, Fox NC.

Neurobiol Aging. 2012 Jul;33(7):1194-202. doi: 10.1016/j.neurobiolaging.2010.11.001. Epub 2010 Dec 15.

47.

Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment.

Schott JM, Bartlett JW, Barnes J, Leung KK, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative investigators.

Neurobiol Aging. 2010 Aug;31(8):1452-62, 1462.e1-2. doi: 10.1016/j.neurobiolaging.2010.04.011.

48.

Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease.

Leung KK, Barnes J, Ridgway GR, Bartlett JW, Clarkson MJ, Macdonald K, Schuff N, Fox NC, Ourselin S; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 Jul 15;51(4):1345-59. doi: 10.1016/j.neuroimage.2010.03.018. Epub 2010 Mar 15.

49.

Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection.

Leung KK, Clarkson MJ, Bartlett JW, Clegg S, Jack CR Jr, Weiner MW, Fox NC, Ourselin S; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 Apr 1;50(2):516-23. doi: 10.1016/j.neuroimage.2009.12.059. Epub 2009 Dec 23.

50.

Linear mixed models for replication data to efficiently allow for covariate measurement error.

Bartlett JW, De Stavola BL, Frost C.

Stat Med. 2009 Nov 10;28(25):3158-78. doi: 10.1002/sim.3713.

PMID:
19777493

Supplemental Content

Loading ...
Support Center